Prostate cancer is the most common form of cancer in men in Germany; however, there is a distinct difference between incidence and mortality.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
The detection of prostate cancer is based on clinical and laboratory testing using serum prostate-specific antigen (PSA) levels and transrectal ultrasound with randomized biopsy.
Multiparametric MR imaging of the prostate can provide valuable diagnostic information for detection of prostate cancer, especially after negative results of a biopsy prior to repeat biopsy.
In addition the use of MR ultrasound fusion-guided biopsy has gained in diagnostic importance and has increased the prostate cancer detection rate.
The prostate imaging reporting and data system (PI-RADS) classification has standardized the reporting of prostate MRI which has positively influenced the acceptance by urologists.
Der Radiologe. 2015 Oct 29 [Epub ahead of print]
P Asbach, M Haas, B Hamm
Klinik für Radiologie, Charité Campus Benjamin Franklin, Hindenburgdamm 30, 12200, Berlin, Deutschland. Klinik für Radiologie, Charité Campus Benjamin Franklin, Hindenburgdamm 30, 12200, Berlin, Deutschland. , Klinik für Radiologie, Charité Campus Benjamin Franklin, Hindenburgdamm 30, 12200, Berlin, Deutschland.